The Roles of Common Variation and Somatic Mutation in Cancer Pharmacogenomics https://t.co/kqT8hgZSNM
RT @Oncology_Ther: Cancer #pharmacogenomics: an #openaccess update on germline alterations that can act as predictive #biomarkers for drug-…
RT @Oncology_Ther: Cancer #pharmacogenomics: an #openaccess update on germline alterations that can act as predictive #biomarkers for drug-…
RT @Oncology_Ther: Cancer #pharmacogenomics: an #openaccess update on germline alterations that can act as predictive #biomarkers for drug-…
RT @Oncology_Ther: Cancer #pharmacogenomics: an #openaccess update on germline alterations that can act as predictive #biomarkers for drug-…
Cancer #pharmacogenomics: an #openaccess update on germline alterations that can act as predictive #biomarkers for drug-induced toxicity and response, and somatic mutations as drug targets https://t.co/M9aIUxJeiw #Irinotecan #erlotinib #sunitinib #baskettr